ADOC SSF, LLC
4Patents
4Active
4Granted
51Portfolio score
Filing activity: Aug 26, 2020 → Oct 28, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12240885B2 | Peptide-MHC compacts | Chemistry; Metallurgy | 0 | Active |
| US12359247B2 | Methods of performing GUIDE-Seq on primary human T cells | Chemistry; Metallurgy | 0 | Active |
| US12276656B2 | Compositions and methods for identification of antigen specific T cells | Chemistry; Metallurgy | 0 | Active |
| US12247061B2 | Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.